CELGENE CORP /DE/
10-Q, EX-27, 2000-11-14
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: CELGENE CORP /DE/, 10-Q, 2000-11-14
Next: APPLIED BIOMETRICS INC, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE>                     5
<CIK>                         0000816284
<NAME>                        CELGENE CORPORATION
<MULTIPLIER>                                               1
<CURRENCY>                                        US DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                                DEC-31-2000
<PERIOD-START>                                   JUL-01-2000
<PERIOD-END>                                     SEP-30-2000
<EXCHANGE-RATE>                                           1
<CASH>                                           159,376,233
<SECURITIES>                                     139,934,298
<RECEIVABLES>                                      9,058,733
<ALLOWANCES>                                         396,832
<INVENTORY>                                        4,354,838
<CURRENT-ASSETS>                                 320,128,019
<PP&E>                                            22,336,529
<DEPRECIATION>                                   (16,262,414)
<TOTAL-ASSETS>                                   331,986,750
<CURRENT-LIABILITIES>                             32,983,728
<BONDS>                                           20,317,772
                                      0
                                                0
<COMMON>                                             708,767
<OTHER-SE>                                       278,164,939
<TOTAL-LIABILITY-AND-EQUITY>                     331,986,750
<SALES>                                           45,201,534
<TOTAL-REVENUES>                                  56,926,817
<CGS>                                              6,404,173
<TOTAL-COSTS>                                     87,077,713
<OTHER-EXPENSES>                                           0
<LOSS-PROVISION>                                           0
<INTEREST-EXPENSE>                                 2,011,785
<INCOME-PRETAX>                                  (19,527,821)
<INCOME-TAX>                                               0
<INCOME-CONTINUING>                              (19,527,821)
<DISCONTINUED>                                             0
<EXTRAORDINARY>                                            0
<CHANGES>                                            450,000
<NET-INCOME>                                     (19,977,821)
<EPS-BASIC>                                            (0.31)
<EPS-DILUTED>                                          (0.31)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission